Statistics on Biotechnology Use  
Results by sector of operation
Company sector. Biotechnology results by main variables and no. of employees. 
Unidades: specified in variables

,Fewer than 250 employees,250 or more employees,Total,
No. of companies carrying out R&D in Biotechnology,1.006,73,1.079,
%Companies according to biotechnology used: Genetic code,34,55,35,
%Companies according to biotechnology used: Functional units,44,53,44,
%Companies according to biotechnology used: Cellular and tissue culturing and engineering,25,47,26,
%Companies according to biotechnology used: Bioprocesses,48,64,49,
%Companies according to biotechnology used: Sub-cellular organisms,8,15,8,
%Companies according to biotechnology used: Bio-computing,23,23,23,
%Companies according to biotechnology used: Nanobiotechnology,15,12,15,
%Companies according to biotechnology used: Other,12,11,12,
Companies in which biotechnology activities are: Main and/or exclusive,503,16,519,
Companies in which biotechnology activities are: A secondary line of business,158,21,179,
Companies in which biotechnology activities are: A tool necessary for production,345,36,381,
%Company by field(s) of ultimate application of biotechnology use: Human Health,47,51,48,
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,22,4,21,
%Company by field(s) of ultimate application of biotechnology use: Food products,33,34,33,
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production,22,21,22,
%Company by field(s) of ultimate application of biotechnology use: Environment,17,21,17,
%Company by field(s) of ultimate application of biotechnology use: Industry,15,8,15,
Personnel in R&D in biotechnology (no. of persons),7.556,2.239,9.795,
Personnel in R&D in biotechnology (no. of persons): Researchers,4.379,1.194,5.573,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,3.177,1.045,4.222,
Personnel in R&D in biotechnology (no. of persons): women,4.032,1.267,5.298,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,2.279,646,2.925,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,1.752,621,2.373,
Personnel in R&D in biotechnology (FTE),5.209,9,1.618,7,6.828,6,
Personnel in R&D in biotechnology (FTE): Researchers,3.191,6,914,9,4.106,5,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,2.018,3,703,8,2.722,1,
Personnel in R&D in biotechnology (FTE): women,2.872,2,939,6,3.811,7,
Personnel in R&D in biotechnology (FTE): (women) Researchers,1.682,6,508,1,2.190,7,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,1.189,5,431,5,1.621,
Internal expenditure on R&D (thousands of euros),402.391,131.434,533.826,
1) By nature of the expense: Current expenses,365.997,126.959,492.955,
1.1) Remuneration to researchers,153.274,50.166,203.439,
1.2) Remuneration to technicians and assistants,67.291,29.559,96.850,
1.3) Other current expenses,145.432,47.234,192.666,
2) By nature of the expense: Capital expenses,36.395,4.476,40.870,
2.1) Land and buildings,6.634,888,7.521,
2.2) Equipment and instruments,28.690,3.388,32.078,
2.3) Acquisition of specific R&D software,1.071,200,1.270,
1) By origin of the funds: National funds,329.975,102.895,432.869,
1.1) Own funds,239.006,80.039,319.046,
1.2) From companies,30.715,8.538,39.253,
1.3) Public Administration funds,57.667,12.396,70.063,
1.4) From Universities,156,0,156,
1.5) From non profit private institutions,2.431,1.921,4.351,
1) By origin of the funds: Foreign funds,72.416,28.540,100.956,
2.1) From EU programmes,18.073,1.998,20.070,
2.2) Other foreign funds,54.344,26.542,80.886,
Purchase of R&D services in biotechnology (thousands of euros),76.625,62.000,138.625,
Purchase of R&D services in biotechnology (thousands of euros): In Spain,64.575,36.539,101.114,
Purchase of R&D services in biotechnology (thousands of euros): Abroad,12.050,25.462,37.512,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital,48,25,46,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information,13,10,13,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources,12,12,12,
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,14,17,14,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets,19,18,19,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels,20,12,19,
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception,18,21,18,
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,37,36,37,
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost,50,44,49,
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,20,11,19,
% Companies that have requested biotechnology patents in Biotechnology,15,22,15,
Number of patents requested,397,69,466,
% Companies with income of an international origin related to biotechnological activities,25,3,20,5,24,9,
% Turnover representing income of an international origin related to biotechnological activities,4,0,7,0,9,
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU,49,5,81,71,3,
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries,50,5,19,1,28,7,
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services,76,2,99,2,92,2,
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain,7,8,.,2,4,
% Income of an international origin related with activities according to the classification: Operating source abroad,3,2,0,4,1,3,
% Income of an international origin related with activities according to the classification: Other,12,7,0,4,4,2,
Notas:

.
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute